DocMorris Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: CH0042615283
CHF
5.57
-0.23 (-4.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About DocMorris Ltd. stock-summary
stock-summary
DocMorris Ltd.
Retailing
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Company Coordinates stock-summary
Company Details
Walzmuehlestrasse 60 , FRAUENFELD None : 8500
stock-summary
Tel: 41 52 724002041 58 7240064
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.93%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Walter Oberhaensli
Chief Executive Officer, Chairman of the Management Board, Executive Director
Prof. Stefan Feuerstein
Non-Executive Chairman of the Board of Directors
Dr. Thomas Schneider
Non-Executive Vice Chairman of the Board of Directors
Prof. Dr. Volker Amelung
Non-Executive Member of the Board of Directors
Mr. Tobias Hartmann
Non-Executive Member of the Board of Directors
Dr. Christian Mielsch
Non-Executive Member of the Board of Directors
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Retailing

stock-summary
Market cap

CHF 288 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.57

stock-summary
Return on Equity

-20.25%

stock-summary
Price to Book

0.60